Parkside Financial Bank & Trust Repligen Corp Transaction History

Parkside Financial Bank & Trust

$702 Million
Q3 2024

A detailed history of Parkside Financial Bank & Trust transactions in Repligen Corp stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 1,071 shares of RGEN stock, worth $165,855. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,071

Previous 971 10.3%

Holding current value

$165,855

Previous $122,000 30.33%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$119.79 - $167.35 $11,979 - $16,735	100 Added 10.3%	1,071 $159,000
Q2 2024 Aug 05, 2024	SELL	$120.0 - $182.95 $10,440 - $15,916	-87 Reduced 8.22%	971 $122,000
Q1 2024 May 01, 2024	BUY	$170.78 - $208.42 $33,985 - $41,475	199 Added 23.17%	1,058 $194,000
Q4 2023 Feb 01, 2024	BUY	$114.17 - $185.35 $13,472 - $21,871	118 Added 15.92%	859 $154,000
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $8,881 - $11,296	64 Added 9.45%	741 $117,000
Q2 2023 Aug 15, 2023	BUY	$138.42 - $180.31 $80,837 - $105,301	584 Added 627.96%	677 $95,000
Q1 2023 May 04, 2023	SELL	$154.26 - $198.1 $462 - $594	-3 Reduced 3.13%	93 $15,000
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $1,136 - $1,543	7 Added 7.87%	96 $16,000
Q3 2022 Nov 01, 2022	BUY	$160.42 - $256.21 $13,956 - $22,290	87 Added 4350.0%	89 $17,000
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $161 - $257	1 Added 100.0%	2 $0
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $247 - $304	1 New	1 $0
Q3 2019 Nov 05, 2019	SELL	$76.65 - $95.51 $4,752 - $5,921	-62 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$49.45 - $62.8 $1,582 - $2,009	32 Added 106.67%	62 $4,000
Q1 2018 May 02, 2018	BUY	$30.92 - $37.27 $432 - $521	14 Added 87.5%	30 $1,000
Q3 2017 Oct 27, 2017	BUY	$36.98 - $46.06 $591 - $736	16	16 $1,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Account

Parkside Financial Bank & Trust Repligen Corp Transaction History